Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viaskin Milk in IgE-mediated cow's milk allergy
NCT02223182Phase 2Completed
- Sponsor
- DBV Technologies
- Start
- Nov 2014
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 2 trial of viaskin milk in IgE-mediated cow's milk allergy (CMA), sponsored by DBV Technologies. Started Nov 2014; status: completed.
02
Drugs
viaskin milk
03
Conditions
IgE-mediated cow's milk allergy (CMA)
Beyond the preview
Go deeper on NCT02223182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02223182.